Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 231-243 , July 2007

Hemodiafiltration History, Technology, and Clinical Results

  • Claudio Ronco

      Affiliations

    • Corresponding Author InformationAddress correspondence to Claudio Ronco, MD, Department of Nephrology, San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, Italy.
    • ,
  • Dinna Cruz

References 

  1. Alwall N. On the artificial kidney (I. Apparatus for dialysis of blood “in vivo”). Acta Med Scand. 1947;128:317–321
  2. Kolff WJ. First clinical experience with the artificial kidney. Ann Intern Med. 1965;62:608–612
  3. Henderson LW, Besarab A, Michaels A, et al. Blood purification by UF and fluid replacement (diafiltration). Trans Am Soc Artif Intern Organs. 1967;17:216–221
  4. Henderson LW, Colton CK, Ford C. Kinetics of HDF (II. Clinical characterization of a new blood cleansing modality). J Lab Clin Med. 1975;85:372–375
  5. Maher JF, Schreiner GE, Waters TJ. Successful intermittent hemo-dialysis-longest reported maintenance of life in true oliguria (181 days). Trans Am Soc Artif Itern Organs. 1960;6:123–126
  6. Bergstrom J. UF without dialysis for removal of fluid and solutes in uremia. Clin Nephrol. 1978;9:156–161
  7. Babb AL, Farrel PC, Uvelli DA, et al. Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Intern Organs. 1972;18:98–105
  8. Babb AL, Strand MJ, Uvelli DA, et al. Quantitative description of dialysis treatment: A dialysis index. Kidney Int. 1975;7(suppl 2):23–28
  9. Henderson LW. Biophysics of UF and hemofiltration. In:  Maher JF editors. Replacement of Renal Function by Dialysis (A Text-book of Dialysis). (ed 3). Dordrecht, The Netherlands: Kluwer Academic Publishers; 1989;p. 300–326
  10. Miller J, von Albertini B, Gardner B, et al. Technical aspects of high flux hemodiafiltration for adequate short (under 2 hours) treatment. Trans Am Soc Artif Intern Organs. 1984;30:377–381
  11. Leber H, Wizemann V, Goubeaud G, et al. Simultaneous hemofiltration/hemodialysis: An effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol. 1978;9:115–121
  12. Kunitomo T, Kirkwood RG, Kumazawa S, et al. Clinical evaluation of postdilution dialysis with a combined ultrafiltration (UF)–hemodialysis (HD) system. Trans Am Soc Artif Intern Organs. 1978;24:169–177
  13. Ronco C, Brendolan A, Crepaldi C, et al. Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol. 2002;13:S53–S61
  14. Maduell F. Hemodiafiltration. Hemodial Int. 2005;9:47–55
  15. Pedrini LA, Cozzi G, Faranna P, et al. Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss. Kidney Int. 2006;69:573–579
  16. Canaud B, Levesque R, Krieter D, et al. On-line hemodiafiltration as routine treatment of end-stage renal failure: Why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?. Blood Purif. 2004;22(suppl 2):40–48
  17. Fiore GB, Guadagni G, Lupi A, et al. A new semiempirical mathematical model for prediction of internal filtration in hollow fiber hemodialyzers. Blood Purif. 2006;24:555–568
  18. Mandolfo S, Corsi A, Wratten ML, et al. Evaluation of hygiene and safety controls for on-line paired hemodiafiltration (PHF). Int J Artif Organs. 2006;29:160–165
  19. Santoro A, Conz PA, De Cristofaro V, et al. Mid-dilution: The perfect balance between convection and diffusion. Contrib Nephrol. 2005;149:107–114
  20. Miwa M, Shinzato T. Push/pull hemodiafiltration: technical aspects and clinical effectiveness. Artif Organs. 1999;23:1123–1126
  21. Ledebo I. On-line preparation of solutions for dialysis: Practical aspects versus safety and regulations. J Am Soc Nephrol. 2002;13(suppl 1):S78–S83
  22. Canaud B, Bosc JY, Leray-Moragues H, et al. On-line haemodiafiltration (Safety and efficacy in long-term clinical practice). Nephrol Dial Transplant. 2000;5(suppl 1):S60–S67
  23. Guth HJ, Gruska S, Kraatz G. On-line production of ultrapure substitution fluid reduces TNF-alpha- and IL-6 release in patients on hemodiafiltration therapy. Int J Artif Organs. 2003;26:181–187
  24. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006;69:2087–2093
  25. Blankestijn PJ, Vos PF, Rabelink TJ, et al. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol. 1995;5:1703–1708
  26. Lin CL, Huang CC, Yu CC, et al. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients. Am J Kidney Dis. 2003;42:524–531
  27. Kerr PB, Argiles A, Flavier JL, et al. Comparison of hemodialysis and hemodiafiltration: A long-term longitudinal study. Kidney Int. 1992;41:1035–1040
  28. Lornoy W, De Meester J, Becaus I, et al. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr. 2006;16:47–53
  29. Lin CL, Yang CW, Chiang CC, et al. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purif. 2001;19:301–307
  30. Rabindranath KS, Strippoli GF, Roderick P, et al. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: Systematic review. Am J Kidney Dis. 2005;45:437–447
  31. Maduell F, Navarro V, Cruz MC, et al. Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis. 2002;40:582–589
  32. Bammens B, Evenepoel P, Verbeke K, et al. Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study. Am J Kidney Dis. 2004;44:278–285
  33. Gonella M, Calabrese G, Mengozzi A, et al. The achievement of normal homocysteinemia in regular extracorporeal dialysis patients. J Nephrol. 2004;17:411–413
  34. Wiesholzer M, Harm F, Hauser AC, et al. Inappropriately high plasma leptin levels in obese haemodialysis patients can be reduced by high flux haemodialysis and haemodiafiltration. Clin Sci (Lond). 1998;94:431–435
  35. Donauer J, Schweiger C, Rumberger B, et al. Reduction of hypotensive side effects during online-haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant. 2003;18:1616–1622
  36. Locatelli F, Marcelli D, Conte F, et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments (The Registro Lombardo Dialisi E Trapianto). Kidney Int. 1999;55:286–293
  37. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 2000;15:1207–1211
  38. Lin CL, Huang CC, Chang CT, et al. Clinical improvement by increased frequency of on-line hemodialfiltration. Ren Fail. 2001;23:193–206
  39. Ward RA, Schmidt B, Hullin J, et al. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol. 2000;11:2344–2350
  40. Ursino M, Coli L, Magosso E, et al. A mathematical model for the prediction of solute kinetics, osmolarity and fluid volume changes during hemodiafiltration with on-line regeneration of ultrafiltrate (HFR). Int J Artif Organs. 2006;29:1031–1040
  41. Yamamoto K, Hiwatari M, Kohori F, et al. Membrane fouling and dialysate flow pattern in an internal filtration-enhancing dialyzer. J Artif Organs. 2005;8:198–205

PII: S1548-5595(07)00056-0

doi: 10.1053/j.ackd.2007.04.002

Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 231-243 , July 2007

Article Tools

* Image Usage & Resolution